Literature DB >> 28239782

Inhibition of Klebsiella pneumoniae growth by selected Australian plants: natural approaches for the prevention and management of ankylosing spondylitis.

V Winnett1,2, J Sirdaarta1,2, A White2, F M Clarke2,3, I E Cock4,5.   

Abstract

A wide variety of herbal remedies are used in traditional Australian medicine to treat inflammatory disorders, including autoimmune inflammatory diseases. One hundred and six extracts from 40 native Australian plant species traditionally used for the treatment of inflammation and/or to inhibit bacterial growth were investigated for their ability to inhibit the growth of a microbial trigger for ankylosing spondylitis (K. pneumoniae). Eighty-six of the extracts (81.1%) inhibited the growth of K. pneumoniae. The D. leichardtii, Eucalyptus spp., K. flavescens, Leptospermum spp., M. quinquenervia, Petalostigma spp., P. angustifolium, S. spinescens, S. australe, S. forte and Tasmannia spp. extracts were effective K. pneumoniae growth inhibitors, with MIC values generally <1000 µg/mL. The T. lanceolata peppercorn extracts were the most potent growth inhibitors, with MIC values as low as 16 µg/mL. These extracts were examined by non-biased GC-MS headspace analysis and comparison with a compound database. A notable feature was the high relative abundance of the sesquiterpenoids polygodial, guaiol and caryophyllene oxide, and the monoterpenoids linalool, cineole and α-terpineol in the T. lanceolata peppercorn methanolic and aqueous extracts. The extracts with the most potent K. pneumoniae inhibitory activity (including the T. lanceolata peppercorn extracts) were nontoxic in the Artemia nauplii bioassay. The lack of toxicity and the growth inhibitory activity of these extracts against K. pneumoniae indicate their potential for both preventing the onset of ankylosing spondylitis and minimising its symptoms once the disease is established.

Entities:  

Keywords:  Autoimmune inflammatory disease; Complementary and alternative therapies; Klebsiella pneumoniae; Linalool; Polygodial; Sesquiterpenoid

Mesh:

Substances:

Year:  2017        PMID: 28239782     DOI: 10.1007/s10787-017-0328-1

Source DB:  PubMed          Journal:  Inflammopharmacology        ISSN: 0925-4692            Impact factor:   4.473


  27 in total

1.  Polygodial, the fungitoxic component from the Brazilian medicinal plant Polygonum punctatum.

Authors:  T M de Almeida Alves; F L Ribeiro; H Kloos; C L Zani
Journal:  Mem Inst Oswaldo Cruz       Date:  2001-08       Impact factor: 2.743

2.  Isolation of an antibacterial sesquiterpenoid from Warburgia salutaris.

Authors:  T Rabe; J van Staden
Journal:  J Ethnopharmacol       Date:  2000-11       Impact factor: 4.360

3.  Lipoproteins from Borrelia burgdorferi applied in liposomes and presented by dendritic cells induce CD8(+) T-lymphocytes in vitro.

Authors:  C Beermann; H Wunderli-Allenspach; P Groscurth; L Filgueira
Journal:  Cell Immunol       Date:  2000-05-01       Impact factor: 4.868

4.  Antibacterial activity of polygodial.

Authors:  Isao Kubo; Ken-ichi Fujita; Sang Hwa Lee; Tae Joung Ha
Journal:  Phytother Res       Date:  2005-12       Impact factor: 5.878

5.  Antibody responses to gut bacteria in ankylosing spondylitis, rheumatoid arthritis, Crohn's disease and ulcerative colitis.

Authors:  H Tiwana; C Wilson; R S Walmsley; A J Wakefield; M S Smith; N L Cox; M J Hudson; A Ebringer
Journal:  Rheumatol Int       Date:  1997       Impact factor: 2.631

6.  Low dose long-term corticosteroid therapy in rheumatoid arthritis: an analysis of serious adverse events.

Authors:  K G Saag; R Koehnke; J R Caldwell; R Brasington; L F Burmeister; B Zimmerman; J A Kohler; D E Furst
Journal:  Am J Med       Date:  1994-02       Impact factor: 4.965

Review 7.  Terpenoids: natural inhibitors of NF-kappaB signaling with anti-inflammatory and anticancer potential.

Authors:  A Salminen; M Lehtonen; T Suuronen; K Kaarniranta; J Huuskonen
Journal:  Cell Mol Life Sci       Date:  2008-10       Impact factor: 9.261

8.  Interaction of four monoterpenes contained in essential oils with model membranes: implications for their antibacterial activity.

Authors:  Mariateresa Cristani; Manuela D'Arrigo; Giuseppina Mandalari; Francesco Castelli; Maria Grazia Sarpietro; Dorotea Micieli; Vincenza Venuti; Giuseppe Bisignano; Antonella Saija; Domenico Trombetta
Journal:  J Agric Food Chem       Date:  2007-06-30       Impact factor: 5.279

Review 9.  Ankylosing spondylitis is linked to Klebsiella--the evidence.

Authors:  Taha Rashid; Alan Ebringer
Journal:  Clin Rheumatol       Date:  2006-12-21       Impact factor: 3.650

10.  Antibacterial and antioxidant activity of essential oil terpenes against pathogenic and spoilage-forming bacteria and cell structure-activity relationships evaluated by SEM microscopy.

Authors:  Hatice Zengin; Ayse H Baysal
Journal:  Molecules       Date:  2014-11-03       Impact factor: 4.411

View more
  2 in total

1.  The medicinal plant Tabebuia impetiginosa potently reduces pro-inflammatory cytokine responses in primary human lymphocytes.

Authors:  Rachael Y M Ryan; Alejandra Fernandez; Yide Wong; John J Miles; Ian E Cock
Journal:  Sci Rep       Date:  2021-03-09       Impact factor: 4.379

Review 2.  Developing New Antimicrobial Therapies: Are Synergistic Combinations of Plant Extracts/Compounds with Conventional Antibiotics the Solution?

Authors:  Matthew J Cheesman; Aishwarya Ilanko; Baxter Blonk; Ian E Cock
Journal:  Pharmacogn Rev       Date:  2017 Jul-Dec
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.